Renal Hemodynamic Function and RAAS Activation Over the Natural History of Type 1 Diabetes
Yuliya Lytvyn(University Health Network), David Z.I. Cherney(University Health Network), Josephine Tse(University Health Network), Hillary A. Keenan(Joslin Diabetes Center), Etienne Sochett(Hospital for Sick Children), Leif E. Lovblom(University of Toronto), Petter Bjornstad(University of Colorado Denver), Alanna Weisman(Mount Sinai Hospital), Leslie Cham(University Health Network), Vesta Lai(University Health Network), Andrew Advani(St. Michael's Hospital), Narinder Paul(University Health Network), Vera Bril(University Health Network), Julie A. Lovshin(Sunnybrook Health Science Centre), Geneviève Boulet(University of Toronto), Bruce A. Perkins(Sinai Health System), Mohammed A. Farooqi(Mount Sinai Hospital), Michael H. Brent(University of Toronto)
Cited by 21
Related Papers
Impact of diabetes on the effects of sodium glucose co-transporter-2 inhibitors on kidney outcomes: collaborative meta-analysis of large placebo-controlled trials
|The Lancet|2022|1k
State of the Art: Iterative CT Reconstruction Techniques
|Radiology|2015|704
Residual Insulin Production and Pancreatic β-Cell Turnover After 50 Years of Diabetes: Joslin Medalist Study
|Diabetes|2010|497
Pyruvate kinase M2 activation may protect against the progression of diabetic glomerular pathology and mitochondrial dysfunction
|Nature Medicine|2017|493
Sodium Glucose Cotransporter-2 Inhibition in Heart Failure
|Circulation|2017|470